Smoking cessation interventions and implementations across multiple settings in Japan: a scoping review and supplemental survey

Nagasawa, Tomomi; Saito, Junko; Odawara, Miyuki; Kaji, Yuki; Yuwaki, Keiichi; Imamura, Haruhiko; Nogi, Kazuya; Nakamura, Masakazu; Shimazu, Taichi

doi:10.1186/s43058-023-00517-0

Implementation Science Communications

Table 3 Barriers and facilitators for the implementation of smoking cessation interventions

From: Smoking cessation interventions and implementations across multiple settings in Japan: a scoping review and supplemental survey

	Consolidated Framework for Implementation Research (CFIR) constructs
ITV components	ITV level
ITV components	1. Intervention characteristics	2. Outer setting	3. Inner setting	4. Individual characteristics	5. Process
Barriers
Approach to population
Smoke-free policies	Relative advantage < Clinical > [46]†	Patient needs and resources < Clinical > [46]†		Knowledge and beliefs about the intervention < Clinical > [71†]
Smoke-free policies		External policy and incentive < Clinical > [71†]
Approach to individual adults
Behavioral counseling and cessation medication		Patient needs and resources < Clinical > [70†, 71†, 72†]	Compatibility < Clinical > [70†, 71†]	Knowledge and beliefs about the intervention < Clinical > [66†, 70†, 71†, 72†]
		External policy and incentive < Clinical > [71†]	Available resources < Clinical > [65†, 69†, 70†, 71†, 72†]	Self-efficacy < Clinical > [70†]
				Other personal attributes < Community > [66†, 70]
Facilitators
Approach to population
Smoke-free policies	Evidence strength and quality < Workplace > [27, 28]	Cosmopolitanism < Workplace, School > [73]	Relative priority < Community > [68†] < Workplace > [27, 28]	Knowledge and beliefs about the intervention < Community > [67†]	Formally appointed internal implementation leaders < Workplace, School > [73]
		Patient needs and resources < Workplace > [27, 28]
		External policy and incentive < Community > [27, 28]
Public awareness about tobacco consumption risk and benefits of tobacco cessation	Evidence strength and quality < Community > [27, 28]	Cosmopolitanism < Workplace, School > [73]	Relative priority < Workplace > [27, 28] < Community > [27, 28]	Knowledge and beliefs about the intervention < Community > [67†]	Formally appointed internal implementation leaders < Workplace, School > [73]
	Cost < Community > [27, 28]	Patient needs and resources < Workplace > [27, 28]		Individual stage of change < Community > [67†]
		External policy and incentive < Community > [27,28 ]		Other personal attributes < Community > [67†]
Approach to individual adults
Behavioral counseling and cessation medication	Evidence strength and quality < Workplace > [27, 28] < Community > [27, 28]	Patient needs and resources < Workplace > [27, 28]	Relative priority < Community > [68†,27,28] < Workplace > [27, 28]	Knowledge and beliefs about the intervention < Clinical > [63†, 64†] < Community > [67†]
	Cost < Community > [27, 28]		Access to knowledge and information < Community > [66†]	Self-efficacy < Clinical > [64†] < Community > [66†]
				Individual stage of change < Community > [67†]
				Other personal attributes < Community > [67†]
Web or internet-based intervention	Evidence strength and quality < Workplace > [27, 28]	Patient needs and resources < Workplace > [27, 28]	Relative priority < Workplace > [27, 28]

^†Original research, < > refers to the setting

Back to article page

ISSN: 2662-2211

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com